Abstract A new epidithiodioxopiperazine compound named verticillin G along with the known compound verticillin D has been isolated from the mycelium of liquid fermentation cultures of a fungal strain Bionectra byssicola F120. The structure of verticillin G was determined on the basis of MS and NMR data. Verticillin G inhibited the growth of Staphylococcus aureus including methicillinresistant and quinolone-resistant S. aureus with MIC (mg/ml) of 3ϳ10.
Gram-positive eubacteria are representative of pathogenic microorganisms. Especially, Staphylococcus aureus is the most clinically important of these pathogens because of its exceptional virulence, stress tolerance, and capacity to accumulate antimicrobial resistances [1] . Methicillinresistant S. aureus (MRSA) is known as a major nosocomial pathogen which has also developed resistance to many other antibiotics. Moreover, MRSA has been reported to acquire resistance to the last-resort antibiotic, vancomycin [2] . These facts suggest that S. aureus would fully acquire resistance to vancomycin in the near future. Therefore, it is increasingly important and necessary to find new classes of antimicrobials.
In the course of our screening for new antibacterials from microbial resources, a new epidithiodioxopiperazine compound named verticillin G (1) together with the known compound verticillin D (2) was isolated from the mycelium of liquid fermentation cultures of a fungal strain Bionectra byssicola F120 (Fig. 1) . Compound 1 is a new derivative of dimeric epidithiodioxopiperazine compounds such as verticillins AϳF [3, 4] , leptosins AϳC, K, K 1 and K 2 [5, 6] , Sch52900 [7] , chaetosin and chetracin A [8] .
In this paper, we report the fermentation, isolation, structure determination and anti-MRSA activity of 1.
Fermentation and Isolation
Fermentation was carried out in a liquid culture medium containing YPS medium (glucose 2%, yeast extract 0.2%, peptone 0.5%, MgSO 4 · 7H 2 O 0.05%, and KH 2 PO 4 0.1%, pH 5.7 before sterilization). A piece of the strain F120 from a mature plate culture was inoculated into a 500-ml Erlenmeyer flask containing 80 ml of the above sterile seed liquid medium and cultured on a rotary shaker (150 rpm) at 28°C for 3 days. For the production of active compounds, 15 ml of the seed culture was transferred into a 1000-ml Erlenmeyer flask containing 300 ml of the YPS medium, and cultivated on a rotary shaker (150 rpm) for 7 days at 28°C. After incubation, the fermented liquid cultures (73 liters) were centrifuged at 6000 rpm for 20 minutes, then only the mycelium parts were extracted with 80% acetone. The acetone extracts was concentrated in vacuo to an aqueous solution, which was then extracted with an equal volume of EtOAc three times. The EtOAc extract (5 g) was subjected to Silica gel (Merck Art No. 7734.9025) column chromatography followed by stepwise elution of CHCl 3 -MeOH (100 : 1, 50 : 1). The active fractions eluted with CHCl 3 -MeOH (50 : 1) were pooled and concentrated in vacuo. The residue dissolved in MeOH was further purified by reversed-phase HPLC column (YMC C 18 , 10ϫ250 mm) chromatography. The column was eluted with MeOH -H 2 O (75 : 25) at a flow rate of 5 ml/minute to afford 1 (2.9 mg) and 2 (35 mg) at retention times of 20.5 and 24.3 minutes, respectively. . These spectral data of 1 were similar to those of compound 2, which was identified as verticillin D by comparison with the literature [3] and on the basis of various spectroscopic analyses. However, these spectral data of 1 showed a double set of signals, suggesting that 1 was not dimeric. The major differences between 1 and 2 in These spectral data clearly indicated the presence of the methylene at C-3 in the other epidithiodioxopiperazine ring. Together with the molecular formula, the 13 C chemical shift (d 85.7) of the quaternary sp 3 carbon of C-11a indicated that the hydrodisulfide group should be attached to C-11a in the dioxopiperazine ring. The remaining structure was also confirmed by HMBC spectral data (Fig.  2) . The relative configuration of 1 was examined by NOESY spectral data (Fig. 3) . Strong NOEs among 11Ј-H, 10Ј-H and 5a-H were observed, while no NOE between 11Ј-H and 5Јa-H was observed. These data indicated that 11Ј-H and 5Јa-H have a trans configuration, and 11Ј-H and the C-10b-C-10bЈ bond have a trans configuration. However, 11-H showed NOEs with 5a-H and 5Јa-H instead of 10-H. These data clearly indicated that 11-H and 5a-H have a cis configuration, and 11-H and the C-10b-C-10bЈ bond have a cis configuration. Considering the absolute configuration of the congener 2 with the [a] value (ϩ225°, c 0.1, MeOH) virtually identical with that (ϩ220°, c 0.1, MeOH) of the literature [3] , this data suggested the absolute configuration of 1 to be the same as that of 2 except for C-11.
Structure Elucidation
1 and 2, the dimeric epidithiodioxopiperazines, exhibited antibacterial activity against S. aureus (S. aureus RN4220 and S. aureus 503), MRSA (S. aureus CCARM 3167 and S. aureus CCARM 3506) and QRSA (S. aureus CCARM 3505 and S. aureus CCARM 3519). 1 showed stronger activity on QRSA with MIC (mg/ml) of 3 than against wild strains and MRSA with MIC (mg/ml) of 10. Interestingly, 2 showed stronger activity on wild strains and MRSA with MIC (mg/ml) of 3 rather than QRSA with MIC (mg/ml) of 10. The epidithiodioxopiperazine compounds such as verticillins, leptosins and Sch52900 were known to have antibacterial and antitumor activity [3, 5] . The antitumor activity of Sch52900 was known to be due to the inhibition of c-fos proto-oncogene induction [7] . The active moiety of the epidithiodioxopiperazines with strong anti-MRSA activity, however, have not been reported. Thus, it is important to further investigate the structure-activity relationship of the epidithiodioxopiperazines.
